PLAYSTUDIOS INC(NASDAQ:MYPS) stock Fundamental Analysis

Fundamental Rating

Overall MYPS gets a fundamental rating of 4 out of 10. We evaluated MYPS against 72 industry peers in the Entertainment industry. No worries on liquidiy or solvency for MYPS as it has an excellent financial health rating, but there are worries on the profitability. MYPS does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

MYPS had negative earnings in the past year.

MYPS had a positive operating cash flow in the past year.

In multiple years MYPS reported negative net income over the last 5 years.

In the past 5 years MYPS always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of -8.88%, MYPS is doing worse than 61.11% of the companies in the same industry.

MYPS has a Return On Equity (-11.72%) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-8.88%
ROE	-11.72%
ROIC	N/A

ROA(3y)-6.41%

ROA(5y)-1.3%

ROE(3y)-8.11%

ROE(5y)-1.5%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

MYPS has a Gross Margin of 74.88%. This is amongst the best in the industry. MYPS outperforms 86.11% of its industry peers.

In the last couple of years the Gross Margin of MYPS has grown nicely.

The Profit Margin and Operating Margin are not available for MYPS so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	74.88%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.2%

GM growth 5Y2.4%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MYPS does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for MYPS has been reduced compared to 1 year ago.

The number of shares outstanding for MYPS has been reduced compared to 5 years ago.

MYPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

MYPS has an Altman-Z score of 2.26. This is not the best score and indicates that MYPS is in the grey zone with still only limited risk for bankruptcy at the moment.

MYPS has a better Altman-Z score (2.26) than 73.61% of its industry peers.

MYPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	2.26

ROIC/WACCN/A

WACC9.05%

2.3 Liquidity

MYPS has a Current Ratio of 2.98. This indicates that MYPS is financially healthy and has no problem in meeting its short term obligations.

With an excellent Current ratio value of 2.98, MYPS belongs to the best of the industry, outperforming 86.11% of the companies in the same industry.

A Quick Ratio of 2.98 indicates that MYPS has no problem at all paying its short term obligations.

MYPS has a better Quick ratio (2.98) than 86.11% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.98
Quick Ratio	2.98

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for MYPS have decreased strongly by -46.67% in the last year.

The Revenue has decreased by -6.90% in the past year.

Measured over the past years, MYPS shows a small growth in Revenue. The Revenue has been growing by 3.87% on average per year.

EPS 1Y (TTM)-46.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-20%

Revenue 1Y (TTM)-6.9%

Revenue growth 3Y0.23%

Revenue growth 5Y3.87%

Sales Q2Q%-12.1%

3.2 Future

Based on estimates for the next years, MYPS will show a very strong growth in Earnings Per Share. The EPS will grow by 30.47% on average per year.

MYPS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.05% yearly.

EPS Next Y88.41%

EPS Next 2Y40.43%

EPS Next 3Y30.47%

EPS Next 5YN/A

Revenue Next Year-10.42%

Revenue Next 2Y-5.75%

Revenue Next 3Y-3.41%

Revenue Next 5Y-5.05%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MYPS. In the last year negative earnings were reported.

Also next year MYPS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MYPS is valued cheaper than 95.83% of the companies in the same industry.

93.06% of the companies in the same industry are more expensive than MYPS, based on the Price/Free Cash Flow ratio.

		Industry Rank	Sector Rank
P/FCF	6.73
EV/EBITDA	1.28

4.3 Compensation for Growth

MYPS's earnings are expected to grow with 30.47% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y40.43%

EPS Next 3Y30.47%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

MYPS does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

PLAYSTUDIOS INC

NASDAQ:MYPS (4/23/2025, 8:23:39 PM)

After market: 1.24 0 (0%)

1.24

-0.02 (-1.59%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryEntertainment

Earnings (Last)03-10 2025-03-10/amc

Earnings (Next)05-13 2025-05-13/amc

Inst Owners38.82%

Inst Owner Change0%

Ins Owners3.56%

Ins Owner Change1.15%

Market Cap155.61M

Analysts52.73

Price Target2.89 (133.06%)

Short Float %0.64%

Short Ratio3.6

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-46.18%

Min EPS beat(2)-110.08%

Max EPS beat(2)17.72%

EPS beat(4)2

Avg EPS beat(4)-8.54%

Min EPS beat(4)-110.08%

Max EPS beat(4)100%

EPS beat(8)5

Avg EPS beat(8)-54.68%

EPS beat(12)8

Avg EPS beat(12)18.21%

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)1

Avg Revenue beat(2)0.2%

Min Revenue beat(2)-1.44%

Max Revenue beat(2)1.83%

Revenue beat(4)2

Avg Revenue beat(4)-1.1%

Min Revenue beat(4)-5.33%

Max Revenue beat(4)1.83%

Revenue beat(8)4

Avg Revenue beat(8)-0.29%

Revenue beat(12)6

Avg Revenue beat(12)0.39%

Revenue beat(16)8

Avg Revenue beat(16)0.58%

PT rev (1m)0%

PT rev (3m)-19.05%

EPS NQ rev (1m)-246.67%

EPS NQ rev (3m)-289.09%

EPS NY rev (1m)-152.44%

EPS NY rev (3m)-168.62%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-3.86%

Revenue NY rev (1m)-4.04%

Revenue NY rev (3m)-5%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.54
P/FCF	6.73
P/OCF	3.4
P/B	0.64
P/tB	1.53
EV/EBITDA	1.28

EPS(TTM)-0.22

EYN/A

EPS(NY)-0.03

Fwd EYN/A

FCF(TTM)0.18

FCFY14.87%

OCF(TTM)0.36

OCFY29.39%

SpS2.31

BVpS1.95

TBVpS0.81

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-8.88%
ROE	-11.72%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	74.88%
FCFM	7.99%

ROA(3y)-6.41%

ROA(5y)-1.3%

ROE(3y)-8.11%

ROE(5y)-1.5%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.2%

GM growth 5Y2.4%

F-Score5

Asset Turnover0.9

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Debt/EBITDA	0
Cap/Depr	49.74%
Cap/Sales	7.81%
Interest Coverage	N/A
Cash Conversion	119.47%
Profit Quality	N/A
Current Ratio	2.98
Quick Ratio	2.98
Altman-Z	2.26

F-Score5

WACC9.05%

ROIC/WACCN/A

Cap/Depr(3y)71.79%

Cap/Depr(5y)97.26%

Cap/Sales(3y)9.92%

Cap/Sales(5y)10.8%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-46.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-20%

EPS Next Y88.41%

EPS Next 2Y40.43%

EPS Next 3Y30.47%

EPS Next 5YN/A

Revenue 1Y (TTM)-6.9%

Revenue growth 3Y0.23%

Revenue growth 5Y3.87%

Sales Q2Q%-12.1%

Revenue Next Year-10.42%

Revenue Next 2Y-5.75%

Revenue Next 3Y-3.41%

Revenue Next 5Y-5.05%

EBIT growth 1Y-274.36%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year328.34%

EBIT Next 3Y66.58%

EBIT Next 5Y49.12%

FCF growth 1Y20.16%

FCF growth 3YN/A

FCF growth 5Y16.46%

OCF growth 1Y-11.57%

OCF growth 3Y10.52%

OCF growth 5Y4.85%

PLAYSTUDIOS INC (MYPS) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens